The Global Biomarkers Market was valued at USD 56.94 Billion in 2024 and is expected to reach USD 172.97 Billion by 2032, growing at a CAGR of 14.9% (2025-2032).
The North America Biomarkers Market was valued at USD 22.40 Billion in 2024 and is expected to reach USD 37.07 Billion by 2032, growing at a CAGR of 6.5% (2025-2032).